T/GXAS 847-2024 Non-small cell lung cancer immune checkpoint inhibitor-associated pneumonia management and treatment guidelines
T/GXAS 847-2024 Non-small cell lung cancer immune checkpoint inhibitor-associated pneumonia management and treatment guidelines
Basic Information
Scope
Scope: This document defines the terms and definitions related to the diagnosis and treatment of immun checkpoint inhibitor-induced pneumonia in non-small cell lung cancer, provides abbreviations, and stipulates the requirements for diagnosis, syndrome differentiation, and treatment. This document is applicable to the diagnosis and treatment of immun checkpoint inhibitor-induced pneumonia in non-small cell lung cancer. Main technical content: This document defines the terms and definitions related to the diagnosis and treatment of immun checkpoint inhibitor-induced pneumonia in non-small cell lung cancer, provides abbreviations, and stipulates the requirements for diagnosis, syndrome differentiation, and treatment. This document is applicable to the diagnosis and treatment of immun checkpoint inhibitor-induced pneumonia in non-small cell lung cancer.